Boston Genetics
Boston Genetics (operating via Genomenon) provides curated genomic intelligence — including the Mastermind database of 26M+ variants and CKB cancer knowledgebase — plus expert clinical diagnostic services to biopharma firms and clinical laboratories.
- Company typePrivate
- Founded2019
- HeadquartersCambridge, United States
- Headcount101–250
- GTM typeB2B
- OfferingSoftware
Boston Genetics firmographics
Firmographics- Name
- Boston Genetics
- Website
- https://bostongen.com
- Company type
- Private
- Founded year
- 2019
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Boston Genetics (operating via Genomenon) provides curated genomic intelligence — including the Mastermind database of 26M+ variants and CKB cancer knowledgebase — plus expert clinical diagnostic services to biopharma firms and clinical laboratories.
- Ownership category
- akta.pro rank
Boston Genetics industry classification
Industry- Product category
- Genomic Intelligence Software
- NAICS
- Medical Laboratories (621511), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- Services-Medical Laboratories (8071)
- akta.pro primary industry
- Genomics & Molecular Diagnostics (Trial Support) (HLAGAEAD)
- akta.pro secondary industries
- Genomic & Multi-Omic Biomarkers (NGS panels, transcriptomics, proteomics, metabolomics) (HLAAAMAJ), Molecular Diagnostics & Genomics Laboratories (HLAFAMAE)
Keywords
Where Boston Genetics is headquartered
LocationHeadquarters
- HQ city
- Cambridge
- HQ country
- United States
- HQ region
- North America
Markets served
Boston Genetics business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Revenue model
- Software Subscriptions: Access to Mastermind genomic database and CKB platform for variant interpretation, likely offered as subscription-based access
- Clinical Diagnostic Services: Expert curation and interpretation services offered as tailored solutions for clinical labs, acting as an extension of client's team
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Multi-year contract | Enterprise/Bespoke pricing |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels7 records
Boston Genetics product offering
Product offeringCore offering
Boston Genetics is a curated data solutions provider for large genomic laboratories, offering a genomic intelligence platform that includes the Mastermind database (covering 26M+ variants) and the Cancer Knowledgebase (CKB) for variant interpretation. The company delivers expert clinical diagnostic services, real-world evidence solutions, and curated genomic data to biopharma firms and clinical labs, helping them accelerate variant curation, reduce turnaround times, and improve diagnostic accuracy.
Product overview
Genomenon offers a unified genomic intelligence platform consisting of Mastermind (core genomic database for germline variants), CKB (Cancer Knowledgebase for somatic variants), and Clinical Diagnostic Services. These products work together to provide comprehensive variant interpretation through literature-driven evidence, connecting genomic data to clinical decisions for both biopharma and clinical lab customers.
Differentiator
Problem solved
Functional benefit
Products and services
- Mastermind Genomic intelligence platform providing literature-driven variant interpretation for germline variants, offering access to article information on more than 26 million variants with curated germline variant content for clinical labs and biopharma.
- CKB (Cancer Knowledgebase) Cancer variant knowledgebase used to interpret cancer variants, connecting them to therapies and clinical trials for somatic variant interpretation in clinical labs and biopharma.
- Clinical Diagnostic Services Expert clinical services including workflow and process optimization, variant/gene curation and interpretation, data accuracy and platform improvements, regulatory compliance, and organizational development for clinical diagnostic laboratories.
- Real World Evidence Literature-driven real-world evidence platform designed for biopharma to accelerate development, expand disease insights, optimize clinical trials, and bring precision therapies to patients.
- Genetic Disease Sponsorship Program providing clinicians and researchers open access to curated genetic evidence to reduce diagnostic barriers and advance scientific understanding.
- Genomic Data Expansive, constantly updated database of curated genomic information for variant analysis and interpretation.
Quantifiable outcome
- Reduced a 1-year patient backlog in 5.5 months
- +5 more outcomes
Companies that use Boston Genetics
Customer profileSegments2 records
Ideal customer profiles2 records
Boston Genetics technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability2 records
Feature4 records
Boston Genetics partnerships and signals
Strategic signalScale indicators8 records
Recent moves5 records
Expansion highlights5 records
Boston Genetics competitors and assessment
Company assessmentBroad incumbents
- Invitae: Invitae (now operating with ArcherDX/PDT) provides clinical genetic testing and interpretation software for rare disease, oncology, and reproductive health — a broad incumbent serving clinical labs and biopharma with overlapping variant interpretation and curation capabilities.
- GeneDx: GeneDx is a clinical genetics laboratory offering exome/genome sequencing and interpretation services to clinicians and biopharma — a broad incumbent that competes with Boston Genetics' clinical lab services arm and has now absorbed Fabric Genomics as its interpretation platform.
- Illumina (Connected Insights / BaseSpace): Illumina offers BaseSpace Variant Interpreter and related tertiary analysis tools bundled with its sequencing instruments — a broad incumbent with overlapping interpretation capabilities, often paired with sequencing-platform lock-in rather than sold as a standalone database.
- Qiagen Digital Insights: Qiagen's Digital Insights business (Ingenuity, QCI, HGMD) provides variant interpretation and knowledge bases used by clinical labs and biopharma — a broad incumbent that competes head-to-head with Mastermind for variant knowledge and clinical decision support, though as part of a much larger sample-to-insight portfolio.
Direct peers
- PierianDx: PierianDx (now part of the Fabric Genomics / GeneDx ecosystem) provides a clinical genomics platform for variant interpretation, tertiary analysis, and clinical reporting — a direct peer in lab-facing genomic interpretation software.
- Congenica: Congenica delivers a clinical genomic analysis platform for rare disease and somatic cancer interpretation used by clinical labs and biopharma — directly comparable in offering curated variant databases, clinical decision support, and laboratory workflow tools.
- Molecular Health: Molecular Health provides genomic clinical decision support software for oncology and rare disease, connecting variants to therapies and clinical evidence — a direct peer in literature-driven, therapy-linking variant interpretation for biopharma and clinical labs.
- SOPHiA Genetics: SOPHiA Genetics offers an AI-driven platform for genomic and multimodal data analysis used by clinical labs and biopharma for variant interpretation and clinical decision support — a directly comparable genomic intelligence and interpretation play targeting the same customer base.
- Fabric Genomics (GeneDx): Fabric Genomics provides AI-powered clinical genomic interpretation software for rare disease and hereditary cancer, serving clinical labs and health systems — a direct competitor in the clinical variant interpretation and curation market Boston Genetics addresses.
Emerging players
- Tempus Labs: Tempus combines molecular profiling, real-world clinical-genomic data, and AI tools for precision medicine, serving both biopharma and providers — an emerging player with overlapping biopharma RWE and clinical genomics use cases, though with a broader data and diagnostics scope than Boston Genetics.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks7 records
Key highlights7 records
Customer concentration
Boston Genetics social profiles
Digital presenceBoston Genetics financial estimates
Financial estimateRevenue estimate
Valuation estimate
Boston Genetics leadership team
Management profileNumber of profiles
Boston Genetics funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Boston Genetics M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Boston Genetics
What does Boston Genetics do?
Boston Genetics is a curated data solutions provider for large genomic laboratories, offering a genomic intelligence platform that includes the Mastermind database (covering 26M+ variants) and the Cancer Knowledgebase (CKB) for variant interpretation. The company delivers expert clinical diagnostic services, real-world evidence solutions, and curated genomic data to biopharma firms and clinical labs, helping them accelerate variant curation, reduce turnaround times, and improve diagnostic accuracy.
Is Boston Genetics a public or private company?
Boston Genetics is a private company. It is classified as unknown and is currently operating.
When was Boston Genetics founded?
Boston Genetics was founded in 2019. It employs 101 to 250 people.
Where is Boston Genetics based?
Boston Genetics is headquartered in Cambridge, United States, in the North America region.
How does Boston Genetics make money?
Two revenue lines are on record. Software Subscriptions are the primary driver. The others are clinical Diagnostic Services.
Who are Boston Genetics's main competitors?
Broad incumbents on record are Invitae, GeneDx, Illumina (Connected Insights / BaseSpace) and Qiagen Digital Insights. Direct peers are PierianDx, Congenica, Molecular Health, SOPHiA Genetics and Fabric Genomics (GeneDx). Tempus Labs is listed as an emerging player.
Does Boston Genetics have an API?
No public API is recorded for Boston Genetics.
What industry is Boston Genetics in?
Boston Genetics's product category is Genomic Intelligence Software. Its primary akta.pro industry code is HLAGAEAD, Genomics & Molecular Diagnostics (Trial Support), with a secondary code of HLAAAMAJ, Genomic & Multi-Omic Biomarkers (NGS panels, transcriptomics, proteomics, metabolomics). Its NAICS code is 621511 and its SIC code is 8071.